1.425
Schlusskurs vom Vortag:
$1.50
Offen:
$1.5
24-Stunden-Volumen:
454.19K
Relative Volume:
0.17
Marktkapitalisierung:
$46.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.14M
KGV:
-2.6389
EPS:
-0.54
Netto-Cashflow:
$-3.99M
1W Leistung:
-5.63%
1M Leistung:
+1.79%
6M Leistung:
-44.98%
1J Leistung:
-66.39%
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Firmenname
Telomir Pharmaceuticals Inc
Sektor
Branche
Telefon
786-396-6723
Adresse
100 SE 2ND ST, MIAMI
Vergleichen Sie TELO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TELO
Telomir Pharmaceuticals Inc
|
1.425 | 50.75M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.02 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.55 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.27 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.19 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-21 | Eingeleitet | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten
Short Interest in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Increases By 43.5% - MarketBeat
What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Analyst Upgrade & Community Verified Watchlist Alerts - newser.com
Will Telomir Pharmaceuticals Inc. bounce back from current supportJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Does Telomir Pharmaceuticals Inc. show high probability of rebound2025 Fundamental Recap & Weekly High Momentum Picks - newser.com
Sentiment analysis tools applied to Telomir Pharmaceuticals Inc.Portfolio Update Report & Reliable Price Breakout Alerts - newser.com
Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio chartsTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
What insider trading reveals about Telomir Pharmaceuticals Inc. stockJuly 2025 Retail & Real-Time Chart Pattern Alerts - newser.com
Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
How Telomir Pharmaceuticals Inc. stock reacts to global recession fears2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Market reaction to Telomir Pharmaceuticals Inc.’s recent newsJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
Why Telomir Pharmaceuticals Inc. stock attracts global investorsJuly 2025 Trends & Community Consensus Picks - newser.com
What technical models suggest about Telomir Pharmaceuticals Inc.’s comeback - newser.com
Will Telomir Pharmaceuticals Inc. rebound enough to break evenFed Meeting & Proven Capital Preservation Methods - newser.com
Forecasting Telomir Pharmaceuticals Inc. price range with options data2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Combining price and volume data for Telomir Pharmaceuticals Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Cincinnati Enquirer
Telomir Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Momentum divergence signals in Telomir Pharmaceuticals Inc. chartVolume Spike & AI Driven Price Forecasts - newser.com
Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):